Advertisement

Related Videos

Deborah Collyar: What's In It for Patients?

Ian Tannock, MD, PhD, DSc, on Near-Equivalence: A Better Question Than Non-Inferiority

Opportunities to Optimize Cancer Policies Panel Discussion

Sarah Yim, MD, on Clinical Development of Biosimilars: Lessons for Interventional Pharmacoeconomics

R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, on Alternative Dispensing Strategies

Advertisement

Advertisement




Jul
12
Today In Oncology
New Research Offers Reassurance About Localized Prostate Cancer Prognosis
Avelumab Plus Cetuximab in Advanced Cutaneous Squamous Cell Carcinoma
Surgery vs Ablation in Small Hepatocellular Carcinoma
Chemoimmunotherapy for Advanced BTC 3-Year Overall Survival Update From the TOPAZ Trial
Optimizing the CAR to the Disease in B-Cell Malignancies
View More 
Advertisement
© 2025 HSP News Service, L.L.C.
Conexiant Oncology Logo